Lukas C. Heukamp

Head of Molecular Pathology, Solid Tumors at HpH Institut für Pathologie und Hämatopathologie Hamburg; Head of Diagnostics Lung Cancer Network NOWEL, Oldenburg

Greater Hamburg Area

see PubMed 'Heukamp L'

HpH Institut für Hämatopathologie Hamburg (12 yrs 6 mos)
- Head of Molecular Pathology of Solid Tumors; Head of Clinical Databases and Bioinformatics
  Mar 2019 - Present · 7 yrs 4 mos
- Pathologist
  2014 - Mar 2019 · 5 yrs 3 mos
NEO New Oncology GmbH (5 yrs 2 mos)
- Key Expert
  Dec 2018 - Aug 2019 · 9 mos
- Chief Medical Officer
  Jul 2014 - Dec 2018 · 4 yrs 6 mos
  New Oncology empowers labs to perform high level molecular diagnostics though CE-IVD integrated reagent kits and bioinformatics. Our test NEOplus has been developed to determine Tumor Mutational Burden (TMB) and reliably detects all actionable genetic alterations, e.g. in EGFR, HER2, KRAS and BRAF, including novel and known fusions, such as ALK, RET, ROS1 and FGFR.
Pathologist at University Hospital Cologne
2011 - Jul 2014 · 3 yrs 7 mos
- Co-PI of the Lung Cancer Group Cologne - Head of Molecular Pathology main fokus on development of next generation sequening based analyses routine diagnostics on FFPE material - Head Immunistochemisty - Head of Histology core facility - Head of Centre of Intragrated Oncology Cologne/Bonn Biobank
Pathologist and Research Fellow at Bonn University
2003 - 2011 · 8 yrs
PhD Student at Leiden University Medical Center
1996 - 2000 · 4 yrs